resveratrol has been researched along with Nervous System Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
da Silva, AD; de Assis, PM; Dutra, RC; Fávero, A; Goliatt, PVZC; Marion, GM; Meinel, RS; Menegasso, JF; Nunes, VSP; Raposo, NRB | 1 |
Chorilli, M; Fonseca-Santos, B | 1 |
Kelly, G | 1 |
Kelly, GS | 1 |
3 review(s) available for resveratrol and Nervous System Disorders
Article | Year |
---|---|
The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems.
Topics: Administration, Intranasal; Animals; Blood-Brain Barrier; Brain; Drug Delivery Systems; Humans; Nanoparticles; Nanotechnology; Nervous System Diseases; Resveratrol | 2020 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Learning; Longevity; Memory; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Longevity; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
1 other study(ies) available for resveratrol and Nervous System Disorders
Article | Year |
---|---|
In silico, in vitro and in vivo studies indicate resveratrol analogue as a potential alternative for neuroinflammatory disorders.
Topics: Animals; Anti-Inflammatory Agents; Computer Simulation; In Vitro Techniques; Inflammation; Lipopolysaccharides; Male; Mice; Molecular Docking Simulation; Nervous System Diseases; Neuroprotective Agents; Resveratrol; Scopolamine | 2020 |